Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Tenax Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +2 vs. Q3 2024
- Shares held
- 1.36M
- +133.3K (+10.8%) vs. Q3 2024
- Total value
- $8.43M
- +$4.17M (+98.1%) vs. Q3 2024
- New holders
- 7
- 2 more added
- Sold out
- 5
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Union Bancaire Privee, UBP SA | 1 | $6 | 0.00% | +1 | New |
| Allworth Financial LP | 1 | $7 | 0.00% | 00.0% | Unchanged |
| UMA Financial Services, Inc. | 1 | $7 | 0.00% | +1 | New |
| UBS Group AG | 3 | $18 | 0.00% | −685−99.6% | Reduced |
| SBI Securities Co., Ltd. | 5 | $31 | 0.00% | +5 | New |
| Bank of America Corp | 28 | $173 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 300 | $1.86K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 13,521 | $83.7K | 0.00% | +13,521 | New |
| Dimensional Fund Advisors LP | 21,006 | $130.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 22,287 | $138.0K | 0.00% | +22,287 | New |
| Geode Capital Management, LLC | 24,354 | $150.8K | 0.00% | +5,964+32.4% | Added |
| Millennium Management LLC | 26,809 | $165.9K | 0.00% | +26,809 | New |
| ADAR1 Capital Management, LLC | 34,693 | $214.8K | 0.04% | −27,730−44.4% | Reduced |
| Vestal Point Capital, LP | 55,189 | $341.6K | 0.02% | −28,144−33.8% | Reduced |
| Morgan Stanley | 74,445 | $460.8K | 0.00% | +74,185+28,532.7% | Added |
| Adage Capital Partners GP, L.L.C. | 83,333 | $515.8K | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 83,333 | $515.8K | 0.45% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 166,666 | $1.03M | 0.00% | +166,666 | New |
| VR Adviser, LLC | 208,333 | $1.29M | 0.09% | 00.0% | Unchanged |
| Vivo Capital, LLC | 208,333 | $1.29M | 0.14% | 00.0% | Unchanged |
| BVF Inc | 339,549 | $2.10M | 0.07% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −29,166−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Lynx1 Capital Management LP | 0 | $0 | 0.00% | −14,751−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,693−100.0% | Sold out |